New drug combo shows promise for Hard-to-Treat cancers
NCT ID NCT03363893
First seen Nov 05, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This study tested a new drug called CT7001, alone or with other cancer treatments, in 124 people with advanced solid tumors like breast and prostate cancer. The main goal was to check safety and side effects. The drug is taken by mouth, and the study looked at how it works in different cancer types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Manchester, M20 4BX, United Kingdom
-
Research Site 10
Liverpool, L69 3BX, United Kingdom
-
Research Site 2
Oxford, OX3 7LE, United Kingdom
-
Research Site 3
London, W2 1NY, United Kingdom
-
Research Site 31
Beverly Hills, California, 90211, United States
-
Research Site 33
Salem, Virginia, 24153, United States
-
Research Site 34
Boston, Massachusetts, 02215, United States
-
Research Site 36
Portland, Oregon, 97239, United States
-
Research Site 37
Tampa, Florida, 33612, United States
-
Research Site 38
Chicago, Illinois, 60611, United States
-
Research Site 39
Columbus, Ohio, 43212, United States
-
Research Site 4
Manchester, M20 4BX, United Kingdom
-
Research Site 44
Austin, Texas, 78705, United States
-
Research Site 46
Dallas, Texas, 75246, United States
-
Research Site 47
Cincinnati, Ohio, 45236, United States
-
Research Site 48
Salt Lake City, Utah, 84112, United States
-
Research Site 54
Tucson, Arizona, 85719, United States
-
Research Site 6
Southampton, SO16 6YD, United Kingdom
-
Research Site 7
Glasgow, G12 0YN, United Kingdom
-
Research Site 8
London, W1G 6AD, United Kingdom
-
Research Site 9
London, SE1 9RT, United Kingdom
-
Research site 11
Brighton, BN2 5BE, United Kingdom
-
Research site 5
Cambridge, CB2 0QQ, United Kingdom
Conditions
Explore the condition pages connected to this study.